搂106.25 濠村効閰嶆柟绮夌殑鐢熶骇鎺у埗(In-process control)

銆€銆€锛坅锛 For each infant formula, a master manufacturing order shall be prepared and approved by a responsible official of the manufacturer. The manufacturer shall establish a quality control system that assures and verifies the addition of each ingredient specified in the manufacturing order.

銆€銆€锛坆锛 Unless each batch of finished product is analyzed as specified in §106.30锛坆锛夛紙1锛? the manufacturer shall analyze each in-process batch for:

銆€銆€锛?锛 Solids;

銆€銆€锛?锛 Protein, fat, and carbohydrates 锛坈arbohydrates either by analysis or by mathematical difference锛堺

銆€銆€锛?锛 The indicator nutrient锛坰锛 in each nutrient premix;

銆€銆€锛?锛 Each nutrient added independently of nutrient premixes during formulation of the product, except for linoleic acid, vitamin D, vitamin K, choline, inositol, and biotin; and

銆€銆€锛?锛 Solids or an appropriate nutrient to confirm proper dilution when final dilution is made after performance of the analyses in paragraph 锛坆锛 锛?锛 through 锛?锛 of this section.